Vermillion, Inc. (Pink Sheets: VRML) has appointed Sandra A. Gardiner as its VP and CFO. In her role as CFO, Ms. Gardiner is going to be responsible for leading all aspects of financial management for Vermillion.
Xplosive Stocks, an online financial publication, provides investors timely stock market information.
Sign Up Today for our Free Stock Newsletter
Ms. Gardiner previously served as the CFO and on the Board of Directors of Bend Research Inc. From 2004-08, she served as CFO and Corporate Secretary of Lipid Sciences, Inc., responsible for all decision making authority for all financial and administrations functions in this development stage Biotech company.
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health.
Sign up for the free Xplosive Stocks newsletter. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by Xplosive Stocks can sign up for free by visiting our website.
About Us
Xplosive Stock is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We focus on Xplosive Stocks and track small cap companies that are on the brink of a financial breakout. To feature a company on our website please contact us at the email listed below.
Please click here to read the full disclaimer.
